Investigation in Progress — No Complaint Filed Yet

BG&G is actively investigating potential securities fraud claims against Alignment Healthcare, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.

About This Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Alignment Healthcare, Inc. (NASDAQ: ALHC).

On October 9, 2026, the Centers for Medicare & Medicaid Services (CMS) released its 2027 Medicare Advantage Star Ratings, revealing that Alignment Healthcare, Inc.’s largest California HMO contract, covering approximately 75% of its health-plan members, had been downgraded from 4.0 to 3.5 stars. The downgrade raised concerns about the Company’s eligibility for quality-bonus payments and the potential impact on future revenue and profitability. Following this news, Alignment Healthcare’s stock price opened approximately 20% lower on October 9, 2026.

What We Are Investigating

  • Whether Alignment Healthcare, Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
  • Whether Alignment Healthcare, Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
  • Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.

What Investors Should Do

If you purchased or acquired ALHC securities and suffered a loss, you may have a claim.
Contact BG&G to share relevant facts or information about your purchase.
There is no cost or obligation — our firm works exclusively on a contingency fee basis.
You do not need to have sold your shares to contact us.

ALHC — Stock Performance

About Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”
— Peretz Bronstein, Founding Partner